Attention:
Card image cap

Patent Protection in Life Sciences: Creative Approaches to Safeguard Your Innovations


Level: Advanced
Runtime: 56 minutes
Recorded Date: September 27, 2023
Click here to share this program
Printer-Friendly Version
Closed Caption

Agenda

Key topics include:
  • Life Science Patents: Latest Regulatory Developments in the US and Canada
  • Current Challenges and Regulatory Issues Faced by Patent Owners and IP Lawyers
  • Notable Cases in the US and Canada
  • What Lies Ahead

For NY - Difficulty Level: Experienced attorneys only (non-transitional)

Description

Patent litigation remains prolific in the life sciences industry as ensuring protection becomes more challenging and complex due to the involvement of technologies. Some issues plaguing patent owners and intellectual property (IP) lawyers concern the Section 101 jurisprudence related to innovations in the life sciences industry. Moreover, landmark cases like Amgen Inc. v. Sanofi continue to shape the patent landscape, posing profound impacts on invention enablement. These and other developments continue to pose risks that practitioners should be wary of. Canadian jurisprudence deals with similar issues and in some cases, patent practice diverges between the US and Canada.

Listen as experienced patent attorneys Melanie Szweras (Bereskin & Parr LLP) and Kevin E. Noonan, Ph.D. (McDonnell Boehnen Hulbert & Berghoff LLP) provide a comprehensive discussion of the latest trends and challenges in protecting patents in the life science sector. Speakers, among other things, will offer practical tips and strategies for navigating this dynamic regulatory environment.

Provided By

Card image cap The Knowledge Group
Card image cap

Panelists

Card image cap

Melanie Szweras

Partner
Bereskin & Parr LLP

Melanie Szweras is a partner with Bereskin & Parr LLP and a member of the Life Science’s practice group. She is also co-leader of the Privacy/Regulatory, Advertising, Marketing & Regulatory practice group.

Melanie’s practice focuses on drafting and prosecution of applications relating to biologics, diagnostics, biotechnology, food and pharmaceuticals. Melanie offers strategic advice and expertise to her clients, provides validity and freedom to operate opinions and is involved in related patent litigation and licensing.

Melanie’s privacy work includes advising organizations on compliance with Canadian privacy laws, including PIPEDA, assisting with preparation of privacy policies, terms and conditions, outsourcing agreements and general management of personal information. Her regulatory work includes advising on Health Canada regulated labelling and advertising and on health-related regulations, such as those relating to notices of compliance, certificates of supplementary protection and the Patented Medicines Price Review Board.

Melanie lectures on aspects of Biotechnology and The Application Process at the University of Toronto’s Patent & Trade Secrets Law course and Osgoode Hall’s LLM Patent Law course. Melanie is the Vice-Chair of the Continuing Professional Development Committee for the Intellectual Property Institute of Canada (IPIC) . Melanie also is the Issues Leader of the American Intellectual Property Law Association (AIPLA) Biotechnology Committee.

Melanie received numerous awards throughout her education, including the Medical Research Council Studentship and a University of Toronto Open Scholarship. She was also the Bronze Medalist for her class of 2003 at Osgoode Hall Law School.

Card image cap

Kevin E. Noonan, Ph.D.

Partner
McDonnell Boehnen Hulbert & Berghoff LLP

Kevin E. Noonan is a partner with McDonnell Boehnen Hulbert & Berghoff LLP and serves as Chair of the firm’s Biotechnology & Pharmaceuticals Practice Group. An experienced biotechnology patent lawyer, Dr. Noonan brings more than 20 years of extensive work as a molecular biologist studying high-technology problems in serving the unique needs of his clients. His practice involves all aspects of patent prosecution, practice before the PTAB, and litigation. He represents pharmaceutical companies both large and small on a myriad of issues, as well as several universities in both patenting and licensing to outside investors. He has also filed amicus briefs in landmark patent and other cases to district courts, the Federal Circuit and the U.S. Supreme Court involving patenting issues relevant to biotechnology.

Dr. Noonan is a frequent speaker, commentator and author on a variety of intellectual property law topics. He is a founding author of the Patent Docs weblog, a site focusing on biotechnology and pharmaceutical patent law. In 2010, he was interviewed for a segment that aired on the television program “60 Minutes” that addressed the issue of gene patenting.


Card image cap

Similar Courses

Card image cap
69 minutes
15 Ways to Win Your Patent Case... And 10 Ways to Lose It
With a nod to Simon & Garfunkel, veteran patent litigator William O’Brien takes you through 15 ways to win – and 10 ways to lose - your patent case. Drawing upon decades of experience representing both patent plaintiffs and defendants in federal district courts, the Federal Circuit, the International Trade Commission, and, more recently, the Patent Trial and Appeal Board, this program guides you through the critical issues you must consider at every stage to ensure that you obtain the best outcome for your company or your clients whenever important patents are in dispute.

New Media Legal

$75

Add to Cart
Card image cap
118 minutes
A Comprehensive Guide on Non-Fungible Tokens (NFTs): Managing Potentials and Perils
In this program, a panel of thought leaders and practitioners assembled by The Knowledge Group will discuss the recent trends and significant challenges surrounding NFTs and the associated legal landscape, including helpful insights to avoid potential risks.">In this program, a panel of thought leaders and practitioners assembled by The Knowledge Group will discuss the recent trends and significant challenges surrounding NFTs and the associated legal landscape, including helpful insights to avoid potential risks.

The Knowledge Group

$165

Add to Cart
Card image cap
60 minutes
AI and Voice: From the Scarlett Johansson Open AI Controversy to the Val Kilmer Miracle
Join Peter Afrasiabi as he takes you through the pros and cons of the Deepfakes Accountability Act, a proposed federal law that would create criminal and civil liability for creators of unauthorized deepfakes.

New Media Legal

$75

Add to Cart
Card image cap
58 minutes
AI Inventions and Patents: Drafting Patents for Successful Licensing and Enforcement of AI Technology
In this CLE program, we will demystify the intricacies of AI patenting and set a clear path to success. Our esteemed speakers, possessing extensive experience in AI patent law, will provide practical insights and actionable advice that will reshape your approach to patenting AI innovations.

The Knowledge Group

$75

Add to Cart
Previous Next